BLP25 liposome vaccine

BLP25脂质体疫苗

Report date: 2024/05/22 20:00:38

Base Information

Drug NameBLP25 liposome vaccine
Drug Alias NameTecemotideStimuvaxLP-BLP-25ONO-7165L-BLP25 +[7] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsMucin-1 inhibitors
TargetsMucin-1
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[33] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesCascadian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAptuit (Deeside) LtdEmd Serono IncNational Cancer Institute +[7] 
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia